相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Systemic and Targeted Delivery of Semaphorin 3A Inhibits Tumor Angiogenesis and Progression in Mouse Tumor Models
Andrea Casazza et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2011)
A hypoxia-dependent upregulation of hypoxia-inducible factor-1 by nuclear factor-κB promotes gastric tumour growth and angiogenesis
S. Y. Nam et al.
BRITISH JOURNAL OF CANCER (2011)
The role of hypoxia inducible factor-1alpha in gynecological cancer
Laura M. S. Seeber et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2011)
Use of a Mouse Model of Pancreatic Neuroendocrine Tumors to Find Pericyte Biomarkers of Resistance to Anti-angiogenic Therapy
M. Franco et al.
HORMONE AND METABOLIC RESEARCH (2011)
An Intact Canonical NF-κB Pathway Is Required for Inflammatory Gene Expression in Response to Hypoxia
Susan F. Fitzpatrick et al.
JOURNAL OF IMMUNOLOGY (2011)
Molecular mechanisms and clinical applications of angiogenesis
Peter Carmeliet et al.
NATURE (2011)
Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases
Peter Carmeliet et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors.
Eric Raymond et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
NORMALIZATION OF THE VASCULATURE FOR TREATMENT OF CANCER AND OTHER DISEASES
Shom Goel et al.
PHYSIOLOGICAL REVIEWS (2011)
IL-4 induces cathepsin protease activity in tumor-associated macrophages to promote cancer growth and invasion
Vasilena Gocheva et al.
GENES & DEVELOPMENT (2010)
Mechanism of Hypoxia-Induced NF-κB
Carolyn Culver et al.
MOLECULAR AND CELLULAR BIOLOGY (2010)
EMT, the cytoskeleton, and cancer cell invasion
Mahmut Yilmaz et al.
CANCER AND METASTASIS REVIEWS (2009)
Role of epithelial-to-mesenchymal transition (EMT) in drug sensitivity and metastasis in bladder cancer
David J. McConkey et al.
CANCER AND METASTASIS REVIEWS (2009)
Accelerated Metastasis after Short-Term Treatment with a Potent Inhibitor of Tumor Angiogenesis
John M. L. Ebos et al.
CANCER CELL (2009)
Antiangiogenic Therapy Elicits Malignant Progression of Tumors to Increased Local Invasion and Distant Metastasis
Marta Paez-Ribes et al.
CANCER CELL (2009)
A Vascular Normalization Index as Potential Mechanistic Biomarker to Predict Survival after a Single Dose of Cediranib in Recurrent Glioblastoma Patients
A. Gregory Sorensen et al.
CANCER RESEARCH (2009)
Role of the hypoxic tumor microenvironment in the resistance to anti-angiogenic therapies
Annamaria Rapisarda et al.
DRUG RESISTANCE UPDATES (2009)
Cellular and molecular pathways linking inflammation and cancer
Chiara Porta et al.
IMMUNOBIOLOGY (2009)
Prevention of hypoxia by myoglobin expression in human tumor cells promotes differentiation and inhibits metastasis
Maria Galluzzo et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Regulation of hypoxia-inducible factor-1α by NF-κB
Patrick van Uden et al.
BIOCHEMICAL JOURNAL (2008)
Molecular signature and therapeutic perspective of the epithelial-to-mesenchymal transitions in epithelial cancers
Michele Sabbah et al.
DRUG RESISTANCE UPDATES (2008)
NF-kappa B Signaling Pathway and Its Therapeutic Implications in Human Diseases
Fazlul H. Sarkar et al.
INTERNATIONAL REVIEWS OF IMMUNOLOGY (2008)
NF-κB and epithelial to mesenchymal transition of cancer
Chengyin Min et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2008)
Tumor angiogenic and hypoxic profiles predict radiographic response and survival in malignant astrocytoma patients treated with bevacizumab and irinotecan
Sith Sathornsumetee et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Modes of resistance to anti-angiogenic therapy
Gabriele Bergers et al.
NATURE REVIEWS CANCER (2008)
Bv8 regulates myeloid-cell-dependent tumour angiogenesis
Farbod Shojaei et al.
NATURE (2007)
Bevacizumab plus irinotecan in recurrent glioblastoma multiforme
James J. Vredenburgh et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
VEGF-targeted cancer therapy strategies: current progress, hurdles and future prospects
Dan G. Duda et al.
TRENDS IN MOLECULAR MEDICINE (2007)
Approval summary: Sunitinib for the treatment of imatinib refractory or intolerant gastrointestinal stromal tumors and advanced renal cell carcinoma
Vicki L. Goodman et al.
CLINICAL CANCER RESEARCH (2007)
A preclinical review of sunitinib, a multitargeted receptor tyrosine kinase inhibitor with anti-angiogenic and antitumour activities
J. G. Christensen
ANNALS OF ONCOLOGY (2007)
Prolyl hydroxylase-1 negatively regulates IκB kinase-β, giving insight into hypoxia-induced NFκB activity
Eoin P. Cummins et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Infiltrating neutrophils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesis
Hiroaki Nozawa et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Pericytes limit tumor cell metastasis
XJ Xian et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors
O Casanovas et al.
CANCER CELL (2005)
Scatter factor/hepatocyte growth factor in brain tumor growth and angiogenesis
R Abounader et al.
NEURO-ONCOLOGY (2005)
Cellular abnormalities of blood vessels as targets in cancer
P Baluk et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2005)
Normalization of tumor vasculature: An emerging concept in antiangiogenic therapy
RK Jain
SCIENCE (2005)
An amino-bisphosphonate targets MMP-9-expressing macrophages and angiogenesis to impair cervical carcinogenesis
E Giraudo et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Schedule-dependent inhibition of hypoxia-inducible factor-1α protein accumulation, angiogenesis, and tumor growth by topotecan in U251-HRE glioblastoma xenografts
A Rapisarda et al.
CANCER RESEARCH (2004)
Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors
G Bergers et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene
S Pennacchietti et al.
CANCER CELL (2003)
分享论文
